These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


503 related items for PubMed ID: 16848921

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D, Patrikakos G.
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
    Büki B, Platz M, Haslwanter T, Jünger H, Avan P.
    Audiol Neurootol; 2011 Jan; 16(1):49-54. PubMed ID: 20523039
    [Abstract] [Full Text] [Related]

  • 27. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P.
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [Abstract] [Full Text] [Related]

  • 30. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M, Marsan J, Schramm D, Robichaud J.
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Gentamicin injections for Ménière disease: comparison of subjective and objective end points.
    Steenerson RL, Hardin RB, Cronin GW.
    Ear Nose Throat J; 2008 Aug; 87(8):452-6. PubMed ID: 18712693
    [Abstract] [Full Text] [Related]

  • 34. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J.
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [Abstract] [Full Text] [Related]

  • 35. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 36. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM, Nedzelski JM, Chen JM, Shipp DB.
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [Abstract] [Full Text] [Related]

  • 37. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.